MUKANOV , K.; MUKANTAYEV , K.; TARLYKOV , P. GPR161 RECEPTOR AS A NOVEL TARGET FOR ANTIBODY-BASED IMMUNOTHERAPY OF TRIPLE-NEGATIVE BREAST CANCER. Eurasian Journal of Applied Biotechnology, [S. l.], n. 1, 2018. DOI: 10.11134/btp.1.2018.4. Disponível em: https://biotechlink.org/index.php/journal/article/view/76. Acesso em: 21 nov. 2024.